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Abstract RBL2H3 cells showed a remarkable increase in their 
level of tryptophan hydroxylase (up to 25-fold), the rate-limiting 
enzyme in serotonin biosynthesis, by stimulation with intracel- 
lular calcium mobilizers A23187, thapsigargin, and tBuBHQ as 
well as by stimulation with an antigen in the presence of IgE. The 
increase in the enzyme protein was visualized by Western blot 
analysis using anti-tryptophan hydroxylase antiserum. The 
enzyme turnover (Hasegawa et al., FEBS Lett., 368 (1995) 
151-154) was not slowed down during the rise in tryptophan 
hydroxylase. Actinomycin D prevented the stimulation-induced 
elevation of the enzyme. These findings strongly suggest hat this 
stimulation was achieved by the accelerated biosynthesis of 
tryptophan hydroxylase. 
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I. Introduction 
Tryptophan hydroxylase (TPH) is a tetrahydrobiopterin-de- 
pendent monooxygenase and is the rate-limiting enzyme in 
serotonin biosynthesis. This enzyme is located in specific neu- 
rons and secretory cells of peripheral organs including the 
pineal gland and gastrointestinal tract [1-3]. Studies on TPH 
have been hampered by difficulties in obtaining the pure en- 
zyme in sufficient quantity and by the lack of an appropriate 
cell culture system, as compared with studies on phenylalanine 
or tyrosine hydroxylase which are also pterin-dependent 
monooxygenases. Rodent mast cells produce serotonin, and 
established cell lines of mast cell origin are available [4-8]. In 
our previous work, we found a very rapid turnover of TPH 
protein (half-life, 15-60 min) which was driven by ATP-de- 
pendent proteolysis in the mast cell lines, RBL2H3 and 
FMA3 [9]. This fast turnover might result in a quick increase 
in the enzyme level by slowing down degradation on demand. 
In terms of the stimulation response, however, little is known 
concerning the circumstances under which cells regulate the 
level of TPH activity or the manner in which this is accom- 
plished. Mast cells discharge vesicular materials including ser- 
otonin. These cells might be equipped with mechanisms cap- 
able of restoring serotonin storage levels after discharge. With 
this possibility in mind, we sought an experimental system 
using mast cell lines in order to study the mechanisms in- 
volved. Although the stimulation-secretion pathway mediated 
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by elevation of the intracellular Ca 2+ concentration has been 
extensively studied [10], the restoration process has been little 
investigated. In the present study, an increase in the TPH level 
was demonstrated in RBL2H3 cells by administration of a 
group of reagents which are known to be intracellular-calcium 
mobilizers as well as by immune stimulation. The increase in 
the level of the enzyme was most probably driven by stimula- 
tion of de novo biosynthesis. 
2. Materials and methods 
Calcium ionophore A23187, actinomycin D, cycloheximide, anti- 
DNP IgE, and its antigen (DNP-conjugated BSA, DNP-BSA) were 
purchased from Sigma (St. Louis, MO). Thapsigargin and 2,5-di-(tert- 
butyl)-l,4-benzohydroquinone (tBuBHQ) were purchased from Alo- 
mone Labs (Israel). Dulbecco's Modified Eagle's Medium (DMEM) 
and Ca2+-free DMEM were obtained from Gibco BRL (Gaithers- 
burg, MD). RBL2H3 (a mast cell line derived from rat basophilic 
leukemia cells) was obtained from The Japanese Cancer Research 
Resources Bank (Tokyo). All cultures were given appropriate antibio- 
tics from the day before and throughout the experiments. In experi- 
ments employing pharmacological agents, cells were placed in serum- 
free medium (buffered with HEPES/NaOH) 2 h before administration. 
Agents with low solubility in water were dissolved in dimethylsulfox- 
ide (DMSO) at a concentration 100-fold greater than the final one 
used unless otherwise stated, so that the vehicle (mainly DMSO) 
would be at an equivalent level in each experimental culture with 
no vehicle effect. 
Cell-free TPH activity was determined as described previously 
[9,11]. In brief, cells were placed in 20 ~tl of phosphate-buffered saline, 
then subjected twice to freezing in liquid nitrogen and thawing in 
water. The disrupted cells were incubated in a mixture consisting of 
30 mM DTT, 50 p.M Fe(NH4)2(SO4)2, and 4 mg/ml catalase in 0.1 M 
Tris-acetate (pH 8.1) for 15 rain at 30°C. Then, another cocktail was 
added to afford a final reaction mixture of 250 I-tM tryptophan, 400 
~tM 6R-tetrahydrobiopterin, 500~tM NADH, 1 mM NSD-1015, 2 mg/ 
ml catalase, and 4.5 I.tg/ml sheep liver dihydropteridine r ductase (Sig- 
ma). The reaction was allowed to proceed for 10 min at 30°C. Due to 
substrate inhibition at higher concentrations of L-tryptophan, the en- 
zyme exhibits its maximum activity under these conditions, where the 
apparent Km is around 110 ~tM for L-tryptophan at a given pteridine 
cofactor concentration. The 5HTP formed was measured by high- 
performance liquid chromatography equipped with a fluorescence 
monitor (JASCO model, FP920) set at 302 nm and 350 nm for ex- 
citation and emission, respectively. 
2.1. Western blot analysis 
Blotted membrane filters were prepared after SDS-polyacrylamide 
gel electrophoresis (PAGE) of the cell extracts as described previously 
[9,12]. TPH protein was visualized using a rabbit polyclonal anti-TPH 
antiserum [2] as the primary antibody and a goat antibody to rabbit 
IgG (horse radish peroxidase-conjugated, Wako, Tokyo) as the sec- 
ondary antibody. Extended color development usually yielded non- 
specific signals what were presumed to be proteolytic degradation 
products [13]. TPH was identified by simultaneous electrophoresis of 
the authentic enzyme which was purified from mouse mastocytoma 
P815 according to Nakata and Fujisawa [7]. 
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3. Results 
Fig. 1. Increase in TPH after addition of an antigen in the presence 
of specific IgE: RBL2H3 cells (1.0x 10 s cells/well of a 96-well mi- 
croassay plate) were placed in serum-free DMEM buffered with 
HEPES/NaOH for 2 h prior to the experiment; hen stimulated 
with anti-DNP mouse IgE (1 pg/ml) for 2 h. Thereafter, they were 
treated with (I) or without (©) DNP-BSA (0.1 ~tg/ml) and kept in 
culture for the indicated periods. TPH activity of the cells was de- 
termined as described in Section 2 (n = 4). Insert: aliquots from in- 
cubations for 0, 2, 4, and 6 h were subjected to SDS-PAGE and 
Western blot analysis, as described in the legend to Fig. 2. 
,.-.150 
i 
0 
to  
O 
" -  100 
E 
. i  
E 
3.1. Induction of  tryptophan hydroxylase 
Immune stimulation of mast cells by antigen in the presence 
of antigen-specific antibody (IgE) results in exocytotic dis- 
charge of the secretory vesicles. RBL2H3 cells retain this abil- 
ity to respond [14,15]; the cells discharged about 20% of the 
cellular serotonin (total: = 1.75 nmol/106 cells) within 1 h. A 
calcium ionophore A23187 (0.08 ~tM) caused serotonin release 
by RBL cells similar to that described for histamine release 
[10]. After immune stimulation (DNP-BSA/IgE), the TPH ac- 
tivity of RBL2H3 cells increased up to about 9-fold (Fig. 1). 
This increase in enzyme level occurred after certain lag period 
and then continued for at least 4 h, and with the highest 
activity observed at around 6 h of incubation. Even when 
DNP-BSA/IgE was washed away after 30-min incubation 
and the enzyme activity was determined at 6 h (from the 
initiation of stimulation), 85% of the maximum activity was 
observed and the initial 60-min incubation similarly resulted 
in about 98% of the maximum activity. This result suggests 
that 1 h stimulation seemed to be of sufficient duration to 
trigger the relevant increase. While serotonin release occurred 
soon after stimulation, the increase in the enzyme level was 
likely to require further elaboration inside the cells. The in- 
crease in enzyme activity was accompanied by an increase in 
the amount of protein which was visualized by Western blot 
analysis using specific antiserum to TPH (insert in Fig. 1). 
When the cells were placed in a Ca2+-free medium, the 
DNP-BSA/IgE treatment was not effective. Exposure of 
RBL2H3 cells to high KC1 medium (30 mM) did not result 
in a significant increase in the TPH level, suggesting that 
voltage gated calcium channels might not be involved in the 
utilization of extracellular calcium. 
3.2. Effect of  various calcium mobilizers 
An increase in TPH activity was observed after a 2-h lag 
period and proceeded for the next 4 h (Fig. 2a). The initial 
enzyme level was typically about 5 pmol 5HTP formed per 
min per 106 cells (the level can vary from culture to culture, as 
mentioned previously [9]), and administration of 0.08 ~tM 
A23187 caused it to rise to about 115 pmol 5HTP/min/10 ~
cells, a level roughly 20-fold higher than the basal level. Re- 
moval of the ionophore from the medium after 1 h did not 
interfere with the subsequent increase, as was the case with 
DNP-BSA/IgE. The above observation suggests that intracel- 
lular calcium mobilization was crucial for the increase in 
TPH. An appreciable augmentation of TPH was also ob- 
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Fig. 2. Increase in TPH by the Ca2+-ionophore A23187: (a) RBL2H3 cells were exposed to 0.08 pM A23187 for the indicated periods. TPH 
activity of the cells was determined as described in Section 2 (n =4). (b) RBL2H3 cells exposed to A23187 as above were washed with PBS and 
disrupted in 1% NP40 containing 1 mM PMSF. The supernatant solution was subjected to SDS-PAGE for Western blot analysis. Lanes 14; 
A23187 for 0, 2, 4, and 6 h (10 ~tg each of extracted protein). Lane 5; 60 ng of purified TPH from mouse mastocytoma P-815. Lane 6; 4.5 ng 
of TPH + 2.5 pg of protein extract from a 6-h incubation. Thin lines represent marker proteins (disregard a thin line next to 43 k), from top 
to bottom; 94 k, 67 k, 43 k, and 30 k. 
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served by administration of thapsigargin (peak at 3 nM), 
tBuBHQ (peak at 10 ~tM) as well as A23187 (peak at 0.08 
~tM) (Fig. 3). All the described increases in TPH activity in 
RBL cells coincided with the increases in the amount of pro- 
tein visualized by Western blot analysis (see Fig. 2b and the 
insert in Fig. 3 for A23187 and thapsigargin, respectively, not 
shown for tBuBHQ). 
3.3. Turnover of tryptophan hydroxylase 
Since the level of TPH in RBL cells is maintained by rapid 
biosynthesis counter-balanced by rapid degradation, we exam- 
ined whether the rise in the enzyme level was due to a slow- 
down in the protein turnover. Turnover was estimated by 
tracing enzyme activity after administration of cycloheximide 
(10 txg/ml), as reported previously [9], both before and during 
the ionophore-induced increase in the enzyme (Fig. 4). Before 
stimulation, the steady-state l vel was 8.2 + 0.9 pmol 5HTP/ 
min/106 cells, and the apparent half-life of TPH was about 60 
min. At 6 h after calcium ionophore administration, the en- 
zyme activity rose roughly 28-fold (232 + 15 pmol 5HTP/min/ 
106 cells), and in this case, the half-life was about 30 min. 
Thus, proteolysis after stimulation was no slower than the 
fast degradation which occurs in the resting stage of the 
cell. This feature was also observed in the case of immune 
stimulation in vitro (data not shown). Generally, the steady- 
state rate of biosynthesis equal to that of degradation, and 
in the present system, the degradation rate was not slower. 
Therefore, the elevated level of TPH activity was judged to 
result from an increase in the rate of biosynthesis. 
3.4. Effect of Actinomycin D
When actinomycin D (10 ~tg/ml) was administered to 
RBL2H3 cells, TPH activity appeared not to be affected for 
at least 4 h, suggesting that the mRNA of TPH is more stable 
than the protein. In the presence of actinomycin D, adminis- 
tration of A23187 (0.1 ~tM) did not raise TPH activity. When 
actinomycin D was administrated at 2 h after addition of 
A23187, TPH activity did not rise. When the inhibitor was 
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Fig. 3. Effect of intracellular calcium mobilizers on cellular TPH ac- 
tivity: RBL2H3 cells were placed in serum-free DMEM 2 h before 
the experiment. The cells were exposed to Ca 2+ mobilizing agents at 
the indicated concentrations for 6 h. Thapsigargin (11), A23187 (e), 
and tBuBHQ (A) were dissolved in DMSO as the vehicle (final 1% 
in the medium). TPH activity of the ceils was determined as de- 
scribed in Section 2 (n = 4). Insert: Cell extracts from thapsigargin 
treatment were subjected to SDS-PAGE and Western blot analysis; 
14 correspond to 10 -9, 3)<10 -9, 10 -s, and 3× 10 -s M thapsigar- 
gin, respectively. 
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Fig. 4. Degradation of TPH before and during A23187-induced le- 
vation: RBL2H3 cells were exposed to 0.1 p.M A23187 for 6 h. Pro- 
tein degradation was shown by blocking protein synthesis with cy- 
cloheximide (CHX, 10 p.g/ml) before (©, see right ordinate) and 
during (O, left ordinate) A23187-induced elevation of TPH activity 
(n = 4). Insert: the same data were plotted on a semi-logarithmic 
scale. 
added half way during the increase in enzyme level (at 4 h, 
Fig. 5), the rise was terminated. 
4. D iscuss ion 
A novel increase in TPH activity by immune stimulation in 
vitro or by administration of a group of agents known as 
intracellular calcium mobilizers was demonstrated with the 
mast cell line RBL2H3. We previously demonstrated that a 
steady-state l vel of TPH is maintained by continuous bio- 
synthesis counter-balanced by fast degradation due to ATP- 
dependent proteolysis [9]. With the increase observed in this 
study, however, the rate of degradation was shown to be un- 
affected. In addition, administration of actinomycin D pre- 
vented ionophore-induced elevation of the enzyme level 
whereas the reagent alone did not affect the level of the en- 
zyme for at least 4 h, which suggests that the increase likely 
involved accelerated transcription of the TPH gene. However, 
the mechanism involved in this acceleration is not yet clear. In 
any case, this rise in the steady-state l vel was driven by an 
increased rate of biosynthesis of the enzyme protein rather 
than by a slowdown in enzyme degradation. 
Administration of an antigen and its specific antibody (IgE) 
is a useful physiological model of stimulation of cells with 
characteristics of mast cells. In this study, stimulation was 
carried out with the calcium mobilizers thapsigargin, 
tBuBHQ, and A23187. Although the mechanisms of action 
differ, these reagents are well known to elevate the intracellu- 
lar calcium concentration; thapsigargin is an inhibitor of ve- 
sicular Ca2+-ATPase [16] and tBuBHQ causes release of Ca 2+ 
from an inositol 1,4,5-tris-phosphate-sensitive Ca 2+ pool [17]. 
These results suggest hat the intracellular rise in the Ca 2+ 
concentration, simultaneously triggered the relevant signal 
transduction cascade, resulting in the observed increase in 
TPH and vesicular secretion. It was noted that all of the 
effective agents, thapsigargin, calcium ionophore A23187, 
and tBuBHQ, exhibited a narrow effective dose range (Fig. 
3). The negative effect at high doses might have counter- 
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Fig. 5. Effect of actinomycin D on the increase in TPH induced by 
A23187:RBL2H3 cells were treated with 0.1 ~M A23187 (O). Acti- 
nomycin D was administered at 10 Ixg/ml to RBL2H3 cells just be- 
fore the addition of ionophore (A) and after 4 h of A23187 expo- 
sure (0). Arrows indicate the time of actinomycin D addition. 
balanced the positive effect, resulting in the observed ose 
dependent inhibition. 
Other cells used in our laboratory, FMA3 (Furth's masto- 
cytoma) and P-815 (Dan Potter's mastocytoma), maintain a
high enzyme level, (100-200 pmol 5HTP/min/106 cells, which 
is 10-20-fold greater than RBL cells under non-stimulating 
conditions). However, these cells showed little increased in 
enzyme activity in response to immune stimulation in vitro 
(DNP-BSA/IgE) or to the calcium ionophore A23187. RBL 
cells show very low enzyme activity under non-stimulating 
conditions but can be upregulated. The mouse mastocytoma 
P-815 retains little activity of L-aromatic amino acid decar- 
boxylase [8], presumably because it was lost at some point 
since first established more than three decades ago. FMA3 
and P-815 cells might also have lost the ability to maintain 
TPH activity at a low level for later up-regulation. On the 
other hand, RBL cells appear to have been maintained selec- 
tively as high responders to immune stimulation. However, 
the strong response of RBL cells seen in this study could be 
attributed to a loss in the ability of natural mast cells for 
masking it. Therefore, the extent o which non-neonatal cells 
might be capable of this response remains to be studied. 
Tyrosine hydroxylase is well known to be activated by 
phosphorylation, mainly by a cyclic AMP-dependent protein 
kinase (lowered Km for BH4 which is sub-saturating in the 
tissue). Phenylalanine hydroxylase is also activated by phos- 
phorylation with the A-kinase (heightened Vm~x). TPH in 
brain is known to increase activity by about 2-fold as a result 
of phosphorylation with calcium-calmodulin-dependent pro- 
tein kinase II, but only in the presence of 14-3-3 protein, a 
group-activating protein affecting various neural proteins [18]. 
Therefore, we were very interested in the phosphorylation f 
this enzyme in RBL2H3 cells. However, there have been no 
reports on phosphorylation f any peripheral TPH. Since the 
strong increase in enzyme activity (15-25-fold) was accompa- 
nied by a rise in enzyme protein, phosphorylation f the en- 
zyme, if any, may not be the predominant mechanism for 
stimulating enzyme activity as seen in the present study. 
With regard to cAMP-related up-regulation of gene expres- 
sion, increases in immunoreactive substances [19] or in the 
relevant mRNA [20] were reported to occur in cultured cells 
of neural origin. These increases which took place over the 
course of several days of culture, seemed to be due to cell 
differentiation. Recently, studies appeared in which trans- 
formed culture cells were used with the recombinant TPH 
gene upstream combined with reporter genes. The gene ex- 
pression measured by CAT activity was demonstrated to be 
accelerated with cAMP [21]. No positive effect of cAMP-re- 
lated agents, including muscaline, bethanechol, forskolin, 
theophylline, or dibutyryl cyclic AMP, have been observed 
in our short-term experiment (less than 8 h, data not shown). 
In conclusion, the increase in TPH observed in this study 
was not driven by enhanced egradation of the eilzyme pro- 
tein, and can be attributed to accelerated biosynthesis. This is 
the first report demonstrating that a serotonin-producing cell
is equipped with mechanisms for increasing the TPH level in 
response to extracellular stimulation. 
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